• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Relamorelin

CAS No. 661472-41-9

Relamorelin ( —— )

产品货号. M34692 CAS No. 661472-41-9

Relamorelin (RM-131),一种生长素类似物,是一种选择性的生长素释放肽/生长激素促分泌素受体 (GHSR) 激动剂,对 GHS-1a 受体的 Ki 值为 0.42 nM。Relamorelin 是一种五肽,具有中枢渗透性。Relamorelin 增加生长激素水平,加速胃排空,具有用于恶病质、胃轻瘫和胃/肠运动障碍研究的潜力。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
2MG ¥6421 有现货
5MG ¥9286 有现货
10MG ¥12516 有现货
25MG ¥17986 有现货
50MG ¥23225 有现货
100MG ¥32054 有现货
500MG 获取报价 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Relamorelin
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Relamorelin (RM-131),一种生长素类似物,是一种选择性的生长素释放肽/生长激素促分泌素受体 (GHSR) 激动剂,对 GHS-1a 受体的 Ki 值为 0.42 nM。Relamorelin 是一种五肽,具有中枢渗透性。Relamorelin 增加生长激素水平,加速胃排空,具有用于恶病质、胃轻瘫和胃/肠运动障碍研究的潜力。
  • 产品描述
    Relamorelin (RM-131), a pentapeptide ghrelin analog, is a selective ghrelin/growth hormone secretagogue receptor (GHSR) agonist with a Ki of 0.42 nM for GHS-1a receptor. Relamorelin is centrally penetrant. Relamorelin increases growth hormone levels and accelerates gastric emptying. Relamorelin has the potential for cachexia, gastroparesis, and gastric/intestinal dysmobility disorders research.
  • 体外实验
    Relamorelin (RM-131) shows ~3 times greater affinity for GHS-1a (Ki=0.42 nM) than native ghrelin (Ki=1.12 nM). Relamorelin is 6 times more potent (EC50=0.71 nM) in activating the GHS-1a receptor than native ghrelin (EC50=4.2 nM) as assessed in vitro by calcium mobilization.
  • 体内实验
    Relamorelin (RM-131; 50-500 nmol/kg/day; s.c.; continuous infusion for 5 days) decreases the loss of body mass and fat mass. Relamorelin (500 nmol/kg/day; continuous infusion for 5 days) increases the food intake and weight gain in rats.RM-131 (250-500?nmol/kg; a single s.c.) stimulates acute food intake in wt but not growth hormone secretagogue receptor (GHR) ko mice.Animal Model:F344/NTacfBR male rats implanted with tumor Dosage:50, 500 nmol/kg/day Administration:SC; continuous infusion at a rate of 0.5 μL/h for 5 d Result:Resulted in an increase in food intake (tumor/saline 41.4 g, tumor/BIM-28131 72.5 g) and weight gain (tumor/ saline -10.3%, tumor / BIM-28131 +19.5%).
  • 同义词
    ——
  • 通路
    GPCR/G Protein
  • 靶点
    GHSR
  • 受体
    GHSR
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    661472-41-9
  • 分子量
    790.97
  • 分子式
    C43H50N8O5S
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    C([C@@H](NC([C@@H](CC=1C=2C(SC1)=CC=CC2)NC(=O)C3CCNCC3)=O)C(N[C@H](C(NC4(C(N)=O)CCNCC4)=O)CC5=CC=CC=C5)=O)C=6C=7C(NC6)=CC=CC7
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. DeBoer MD, et, al. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology. 2007 Jun;148(6):3004-12.?
产品手册
关联产品
  • NF-56-EJ40 hydrochlo...

    NF-56-EJ40 hydrochloride is a potent, high-affinity, and highly selective human SUCNR1 (GPR91) antagonist with an IC50 of 25 nM and a Ki of 33 nM, and shows almost no activity towards rat SUCNR1. NF-56-EJ40 hydrochloride has high affinity for humanized rat SUCNR1 with a Ki value of 17.4 nM.

  • Ibutamoren mesylate

    一种非肽类、强效、选择性、口服活性的生长素释放肽受体 (GHSR) 激动剂,EC50 为 1.3 nM(从大鼠垂体细胞中释放 GH)。

  • TAPI-1

    TAPI-1 是一种 ADAM17/TACE 抑制剂,可抑制细胞因子受体的脱落。